Literature DB >> 32892356

The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications.

Milad Moloudizargari1, Ali Govahi1, Marjan Fallah2, Mohammad A Rezvanfar3, Mohammad H Asghari4, Mohammad Abdollahi3.   

Abstract

Mesenchymal stem cells (MSCs) are mesenchymal precursors of various origins, with well-known immunomodulatory effects. Natural killer (NK) cells, the major cells of the innate immune system, are critical for the antitumor and antiviral defenses; however, in certain cases, they may be the main culprits in the pathogenesis of some NK-related conditions such as autoimmunities and hematological malignancies. On the other hand, these cells seem to be the major responders in beneficial phenomena like graft versus leukemia. Substantial data suggest that MSCs can variably affect NK cells and can be affected by these cells. Accordingly, acquiring a profound understanding of the crosstalk between MSCs and NK cells and the involved mechanisms seems to be a necessity to develop therapeutic approaches based on such interactions. Therefore, in this study, we made a thorough review of the existing literature on the interactions between MSCs and NK cells with a focus on the underlying mechanisms. The current knowledge herein suggests that MSCs possess a great potential to be used as tools for therapeutic targeting of NK cells in disease context and that preconditioning of MSCs, as well as their genetic manipulation before administration, may provide a wider variety of options in terms of eliciting more specific and desirable therapeutic outcomes. Nevertheless, our knowledge regarding the effects of MSCs on NK cells is still in its infancy, and further studies with well-defined conditions are warranted herein.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  NK; autoimmunity; cancer; immunomodulation; stem cell

Year:  2020        PMID: 32892356     DOI: 10.1002/jcp.30038

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

Review 2.  Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.

Authors:  Lu Wang; Yun Li; Moyan Xu; Zihui Deng; Yan Zhao; Mengmeng Yang; Yuyan Liu; Rui Yuan; Yan Sun; Hao Zhang; Heming Wang; Zhirong Qian; Hongjun Kang
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 8.786

Review 3.  Stem Cell-Derived Exosome as Potential Therapeutics for Microbial Diseases.

Authors:  Somayeh Keshtkar; Maryam Kaviani; Saeede Soleimanian; Negar Azarpira; Zahra Asvar; Sara Pakbaz
Journal:  Front Microbiol       Date:  2022-02-14       Impact factor: 5.640

Review 4.  Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential.

Authors:  Rui Alvites; Mariana Branquinho; Ana C Sousa; Bruna Lopes; Patrícia Sousa; Ana Colette Maurício
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

Review 5.  Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.

Authors:  Batol Abbasi; Karim Shamsasenjan; Majid Ahmadi; Seyedeh Ameneh Beheshti; Mahshid Saleh
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

Review 6.  Perinatal derivatives: How to best characterize their multimodal functions in vitro. Part C: Inflammation, angiogenesis, and wound healing.

Authors:  Ana I Flores; Caterina Pipino; Urška Dragin Jerman; Sergio Liarte; Florelle Gindraux; Mateja Erdani Kreft; Francisco J Nicolas; Assunta Pandolfi; Larisa Tratnjek; Bernd Giebel; Michela Pozzobon; Antonietta R Silini; Ornella Parolini; Günther Eissner; Ingrid Lang-Olip
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

Review 7.  Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells.

Authors:  Madina Sarsenova; Yevgeniy Kim; Kamila Raziyeva; Bexultan Kazybay; Vyacheslav Ogay; Arman Saparov
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

8.  Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.

Authors:  Quan Zhang; Kang Huang; Jianlei Lv; Xiang Fang; Jun He; Ailian Lv; Xuan Sun; Lamei Cheng; Yanjun Zhong; Shangjie Wu; Yao Dai
Journal:  Front Med (Lausanne)       Date:  2021-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.